Adolore BioTherapeutics Announces Publication of Compelling Preclinical Efficacy and Safety Data Supporting Adolore's Non-opioid Analgesic Gene Therapy, ADLR-1001, For Treatment of Moderate to Severe Chronic Knee Pain Due to Osteoarthritis (OA)

by AdoloreJTC24 | Jul 30, 2024 | Press Releases

This publication validates Adolore's approach for the intracellular delivery of a non-opioid analgesic minigene to targeted sensory neurons via local administrationData provide a robust preclinical proof-of-concept for this JDNI8-rdHSV-based carbonic anhydrase-8...

Adolore BioTherapeutics to Present at the Virtual Investor Pitch Conference

by AdoloreJTC24 | Jun 10, 2024 | Press Releases

Live video webcast on Monday, June 17th at 10:00 AM ET DELRAY BEACH, FL / June 10, 2024 / Adolore BioTherapeutics (“Adolore” or the “Company”), a biotechnology company focused on developing breakthrough opioid-free gene therapy treatments for...

Adolore BioTherapeutics Outlines Strategy for its Next Generation, Disease-Modifying, Non-Opioid Analgesic Gene Therapies for the Treatment of Chronic Pain

by AdoloreJTC24 | May 21, 2024 | Press Releases

Development program for the treatment of osteoarthritis (OA) chronic knee pain is fully funded through the first-in-human clinical study by a UG3/UH3 grant awarded by NIH/NINDS HEAL programOngoing progress with IND-enabling studies of ADLR-1001 gene therapy for the...

Adolore BioTherapeutics Announces Publication Demonstrating Carbonic Anhydrase-8 Gene Therapy (rdHSV-CA8) Decreased Pain-Sensing Neuronal Excitability by Activating Kv7 Voltage-Gated Potassium Channels

by AdoloreJTC24 | May 16, 2024 | Press Releases

Findings highlight the advantages of Adolore’s approach for the delivery of proprietary gene therapy directly to specialized pain-sensing peripheral nerves (nociceptors) that mediate profound analgesia with the potential to address the great unmet need for...

Adolore BioTherapeutics Announces Issuance of First U.S. Patent Covering CA8* Gene Therapies to Treat Chronic Pain

by AdoloreJTC24 | Mar 4, 2024 | Press Releases

Patent and CA8* gene therapy technology licensed by Adolore BioTherapeutics from the University of MiamiCompany advancing development of rdHSV-CA8* gene therapy for the treatment of chronic osteoarthritis (OA) knee pain toward an INDDELRAY BEACH, FL / March 4, 2024 /...